BioPharmX Shares Up 6.6%, Foamix Pharma Shares Down 5.3%; Earlier BioPharmX Announced It Would Present At ROTH Conf. March 12th; BZ NOTE: These Cos. Are Developing Competing Acne Treatments Using Minocycline
Hal Lindon